129 related articles for article (PubMed ID: 11748284)
1. CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells.
Small BA; Dressel SA; Lawrence CW; Drake DR; Stoler MH; Enelow RI; Braciale TJ
J Exp Med; 2001 Dec; 194(12):1835-46. PubMed ID: 11748284
[TBL] [Abstract][Full Text] [Related]
2. Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8(+) T cell recognition.
Zhao MQ; Stoler MH; Liu AN; Wei B; Soguero C; Hahn YS; Enelow RI
J Clin Invest; 2000 Sep; 106(6):R49-58. PubMed ID: 10995793
[TBL] [Abstract][Full Text] [Related]
3. Type II pneumocyte-CD8+ T-cell interactions. Relationship between target cell cytotoxicity and activation.
Zhao MQ; Amir MK; Rice WR; Enelow RI
Am J Respir Cell Mol Biol; 2001 Sep; 25(3):362-9. PubMed ID: 11588015
[TBL] [Abstract][Full Text] [Related]
4. Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology.
Wiley JA; Cerwenka A; Harkema JR; Dutton RW; Harmsen AG
Am J Pathol; 2001 Jan; 158(1):119-30. PubMed ID: 11141485
[TBL] [Abstract][Full Text] [Related]
5. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.
Liu AN; Mohammed AZ; Rice WR; Fiedeldey DT; Liebermann JS; Whitsett JA; Braciale TJ; Enelow RI
Am J Respir Cell Mol Biol; 1999 May; 20(5):849-58. PubMed ID: 10226053
[TBL] [Abstract][Full Text] [Related]
6. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial.
Cerwenka A; Morgan TM; Dutton RW
J Immunol; 1999 Nov; 163(10):5535-43. PubMed ID: 10553081
[TBL] [Abstract][Full Text] [Related]
7. Expression of the DX5 antigen on CD8+ T cells is associated with activation and subsequent cell death or memory during influenza virus infection.
Kambayashi T; Assarsson E; Chambers BJ; Ljunggren HG
Eur J Immunol; 2001 May; 31(5):1523-30. PubMed ID: 11465109
[TBL] [Abstract][Full Text] [Related]
8. A lung-specific neo-antigen elicits specific CD8+ T cell tolerance with preserved CD4+ T cell reactivity. Implications for immune-mediated lung disease.
Enelow RI; Stoler MH; Srikiatkhachorn A; Kerlakian C; Agersborg S; Whitsett JA; Braciale TJ
J Clin Invest; 1996 Aug; 98(4):914-22. PubMed ID: 8770862
[TBL] [Abstract][Full Text] [Related]
9. Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection.
Cerwenka A; Morgan TM; Harmsen AG; Dutton RW
J Exp Med; 1999 Jan; 189(2):423-34. PubMed ID: 9892624
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease.
Enelow RI; Mohammed AZ; Stoler MH; Liu AN; Young JS; Lou YH; Braciale TJ
J Clin Invest; 1998 Nov; 102(9):1653-61. PubMed ID: 9802879
[TBL] [Abstract][Full Text] [Related]
11. Smad4 promotes differentiation of effector and circulating memory CD8 T cells but is dispensable for tissue-resident memory CD8 T cells.
Hu Y; Lee YT; Kaech SM; Garvy B; Cauley LS
J Immunol; 2015 Mar; 194(5):2407-14. PubMed ID: 25637015
[TBL] [Abstract][Full Text] [Related]
12. Potent immunotherapy against well-established thymoma using adoptively transferred transgene IL-6-engineered dendritic cell-stimulated CD8+ T-cells with prolonged survival and enhanced cytotoxicity.
Kalyanasundaram Bhanumathy K; Zhang B; Xie Y; Xu A; Tan X; Xiang J
J Gene Med; 2015; 17(8-9):153-60. PubMed ID: 26212685
[TBL] [Abstract][Full Text] [Related]
13. IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer.
Rodolfo M; Zilocchi C; Accornero P; Cappetti B; Arioli I; Colombo MP
J Immunol; 1999 Aug; 163(4):1923-8. PubMed ID: 10438927
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: pulmonary immunopathology mediated by antigen-specific expression of TNF-alpha by antiviral CD8+ T cells.
Xu L; Yoon H; Zhao MQ; Liu J; Ramana CV; Enelow RI
J Immunol; 2004 Jul; 173(2):721-5. PubMed ID: 15240656
[TBL] [Abstract][Full Text] [Related]
15. Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells.
Lo D; Freedman J; Hesse S; Palmiter RD; Brinster RL; Sherman LA
Eur J Immunol; 1992 Apr; 22(4):1013-22. PubMed ID: 1348026
[TBL] [Abstract][Full Text] [Related]
16. In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines.
Cerwenka A; Carter LL; Reome JB; Swain SL; Dutton RW
J Immunol; 1998 Jul; 161(1):97-105. PubMed ID: 9647212
[TBL] [Abstract][Full Text] [Related]
17. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.
Ye Z; Tang C; Xu S; Zhang B; Zhang X; Moyana T; Yang J; Xiang J
Cell Mol Immunol; 2007 Aug; 4(4):277-85. PubMed ID: 17764618
[TBL] [Abstract][Full Text] [Related]
18. Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells.
Wolint P; Betts MR; Koup RA; Oxenius A
J Exp Med; 2004 Apr; 199(7):925-36. PubMed ID: 15051762
[TBL] [Abstract][Full Text] [Related]
19. CD8(+) T cells responding to alveolar self-antigen lack CD25 expression and fail to precipitate autoimmunity.
Tosiek MJ; Bader SR; Gruber AD; Buer J; Gereke M; Bruder D
Am J Respir Cell Mol Biol; 2012 Dec; 47(6):869-78. PubMed ID: 22984087
[TBL] [Abstract][Full Text] [Related]
20. Long-term surviving influenza infected cells evade CD8+ T cell mediated clearance.
Fiege JK; Stone IA; Dumm RE; Waring BM; Fife BT; Agudo J; Brown BD; Heaton NS; Langlois RA
PLoS Pathog; 2019 Sep; 15(9):e1008077. PubMed ID: 31557273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
